[HTML][HTML] Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 …

I Alberts, H Sari, C Mingels, A Afshar-Oromieh, T Pyka… - Cancer Imaging, 2023 - Springer
Recently introduced long-axial field-of-view (LAFOV) PET/CT systems represent one of the
most significant advancements in nuclear medicine since the advent of multi-modality …

[HTML][HTML] Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

S Piron, J Verhoeven, C Vanhove, F De Vos - Nuclear Medicine and …, 2022 - Elsevier
Prostate specific membrane antigen (PSMA) is an attractive target for molecular imaging of
prostate cancer and several other solid tumors because of its overexpression in prostate …

[HTML][HTML] Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis

S Hoberück, S Löck, A Borkowetz, U Sommer… - EJNMMI research, 2021 - Springer
Background The analysis aimed to compare the radiotracers [68 Ga]-Ga-PSMA-11 and [18
F]-F-PSMA-1007 intraindividually in terms of malignant lesions, mi (molecular-imaging) TNM …

[HTML][HTML] The role of PSMA PET/CT in the primary diagnosis and follow-up of prostate cancer—a practical clinical review

AR Lisney, C Leitsmann, A Strauß, B Meller… - Cancers, 2022 - mdpi.com
Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …

[HTML][HTML] Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov …

I Alberts, C Mingels, HD Zacho, S Lanz… - European journal of …, 2021 - Springer
Abstract Purpose Amongst others,[68 Ga] Ga-PSMA-11 and [18 F] PSMA-1007 are available
for the detection of recurrent prostate cancer (rPC). There are currently limited data …

[HTML][HTML] Feasibility of late acquisition [68Ga] Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer—first …

I Alberts, G Prenosil, C Mingels, KP Bohn… - European journal of …, 2021 - Springer
Purpose While acquisition of images in [68 Ga] Ga-PSMA-11 following longer uptake times
can improve lesion uptake and contrast, resultant imaging quality and count statistics are …

[HTML][HTML] Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

C Mingels, KP Bohn, A Rominger… - European journal of …, 2022 - Springer
Aim Despite increasing use for the detection of biochemically recurrent prostate cancer
(rPC), the diagnostic accuracy of positron emission tomography/computed tomography …

[HTML][HTML] Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study

M Bauckneht, A Miceli, A Signori, D Albano… - European …, 2023 - Springer
Objectives Increased detection of prostate cancer (PCa) recurrences using [68Ga] Ga-PSMA-
11 PET/CT has been reported by adding forced diuresis or late-phase imaging to the …

[HTML][HTML] Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

PA Glemser, LT Rotkopf, CH Ziener… - Cancer Imaging, 2022 - Springer
Abstract Aim To compare [68Ga] PSMA-11 PET-CT,[68Ga] PSMA-11 PET-MRI and MRI in a
cohort of prostate cancer (PCa) patients in biochemical recurrence after initial curative …

[HTML][HTML] Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review

M Zhu, Z Liang, T Feng, Z Mai, S Jin, L Wu, H Zhou… - Diagnostics, 2023 - mdpi.com
Prostate cancer (PCa) faces great challenges in early diagnosis, which often leads not only
to unnecessary, invasive procedures, but to over-diagnosis and treatment as well, thus …